Expanding Multilevel Multicomponent Mentorship in Kidney Disease Research

肾脏疾病影响着全世界近三分之一的成年人，并且与显着的发病率和发病率相关。 死亡率。在过去的三十年里，人们对肾脏的认识取得了巨大进展 最近导致新疗法的疾病机制，包括医疗保健提供策略 加强健康信息的提供并促进成功的自我保健，但生活质量以及 生存率仍然很低，尤其是那些患有包括肾衰竭在内的晚期肾病的人。 重要的是，NIH/NIDDK 已进行投资，确保患者合作伙伴成为治疗过程中不可或缺的一部分。 确定优先顺序并开展研究。同样，NIH/NIDDK 正在进一步投资以确保学术 研究人员也多样化且具有代表性。这是整个肾脏领域的一个关键目标 疾病研究包括基础科学、临床和转化以及政策研究。卡瓦诺博士是 肾脏疾病临床试验、健康素养及其影响、形成性研究领域公认的专家 阐明利益相关者的观点并将其纳入研究和社区参与中。她的目标是 利用 K26 NIDDK 研究者奖的支持来支持早期职业研究人员的指导 从不同的背景专注于培养下一代科学家带来变革 肾脏疾病研究的进展。候选人的近期和长期职业目标是 研究人员发展的领导者直接符合 NIH K26 奖项的目标，以提供 支持获奖者受保护的时间致力于指导培训和文化敏感的指导 博士后学生。具体来说，这个奖项将使她能够专注于多层次的发展 指导计划，以促进新兴早期研究者的职业发展。该奖项将提供 候选人有受保护的时间专门致力于执行严格的研究，作为主要的、 协作、宣传和网络导师，并培养研究方面的指导技能。她的目标是 招募和指导博士后研究员和初级教师，以实现肾脏临床研究事业的成功 疾病并支持当前学员的职业发展。她将通过以下方式实现这一目标 利用她的研究计划资源以及强大的机构、区域和国家资源。 目标包括 (a) 持续进行有影响力的研究，以扩大受训者的机会； (b) 发展和 部署新颖的文化定制心理和工具宣传肾脏疾病研究 导师计划； (c) 获得专家咨询委员会通报的指导技能培训；和（四） 执行招聘计划，以识别和吸引来自不同背景的学员。完成 这些目标将促进来自不同背景的肾脏疾病科学家的职业发展 使致力于了解和消除肾脏疾病的未来教师队伍多样化并发展壮大。

Kidney disease affects nearly one in three adults worldwide and is associated with significant morbidity and mortality. Throughout the last three decades there has been tremendous progress in understanding kidney disease mechanisms that have led recently to new therapies including healthcare delivery strategies to enhance delivery of health information and promote successful self-care, however quality of life as well as survival remains poor especially for those living with advanced kidney disease including kidney failure. Importantly the NIH/NIDDK has invested in ensuring that patient partners are integral to the process of prioritizing as well as carrying out research. Similarly, NIH/NIDDK is further investing in ensuring the academic research workforce is also diverse and representative. This is a critical objective across the spectrum of kidney disease research including basic science, clinical and translational, and policy research. Dr. Cavanaugh is a well recognized expert in kidney disease clinical trials, health literacy and its implications, formative research to elucidate and integrate stakeholder perspectives into research and community engagement. Her objective is to use the support of the K26 NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds to focus on training the next generation of scientists to bring transformative advancements in kidney disease research. The candidate’s immediate and long-term career objectives to be a leader in research faculty development are directly in line with the goals of the NIH K26 award, to provide support for protected time for awardees to devote to mentoring training and culturally-sensitive mentoring for post-doctoral students. Specifically, this award will allow her to focus on the development of a multi-level mentoring program to facilitate the career development of emerging early investigators. This award will provide protected time for the candidate to devote specifically to executing rigorous research, serving as a primary, collaborative, advocacy and network mentor, and to developing mentoring skills in research. Her objective is to recruit and mentor post-doctoral fellows and junior faculty for successful clinical research careers in kidney disease and to support the career advancement of her current trainees. She will accomplish this objective by leveraging her research program resources as well as the robust institutional, regional and national resources. The aims include (a) continued impactful research to expand opportunities for mentees; (b) development and deployment of a novel culturally tailored psychological and instrumental advocacy kidney disease research mentor program; (c) acquisition of mentoring skills training informed by an expert advisory committee; and (d) execution of recruitment programs to identify and engage mentees from diverse backgrounds. Completion of these aims will enhance the career advancement of kidney disease scientists from diverse backgrounds to diversify and grow the future workforce of faculty dedicated to understanding and eliminating kidney disease.